On January 24, 2023, Sio Gene Therapies Inc. (NASDAQ: SIOX) opened at $0.44, lower -1.73% from the last session. During the day, the shares moved up to $0.4425 and dropped to $0.429 before settling in for the closing price of $0.44. Price fluctuations for SIOX have ranged from $0.23 to $1.20 over the past 52 weeks.
Will You Miss Out On This Growth Stock Boom?
A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.
And this is just one of our
5 Best Growth Stocks To Own For 2023.
Sponsored
Company’s average yearly earnings per share was noted -58.00% at the time writing. With a float of $55.07 million, this company’s outstanding shares have now reached $73.77 million.
Let’s look at the performance matrix of the company that is accounted for 12 employees.
Sio Gene Therapies Inc. (SIOX) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Sio Gene Therapies Inc. is 25.55%, while institutional ownership is 30.10%.
Sio Gene Therapies Inc. (SIOX) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 3/30/2022, the company posted -$0.18 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.2) by $0.02. This company achieved a return on equity of -78.26. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -58.00% per share during the next fiscal year.
Sio Gene Therapies Inc. (NASDAQ: SIOX) Trading Performance Indicators
Check out the current performance indicators for Sio Gene Therapies Inc. (SIOX). In the past quarter, the stock posted a quick ratio of 6.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.68
Technical Analysis of Sio Gene Therapies Inc. (SIOX)
Sio Gene Therapies Inc. (NASDAQ: SIOX) saw its 5-day average volume 0.46 million, a positive change from its year-to-date volume of 0.41 million. As of the previous 9 days, the stock’s Stochastic %D was 21.34%. Additionally, its Average True Range was 0.02.
During the past 100 days, Sio Gene Therapies Inc.’s (SIOX) raw stochastic average was set at 84.07%, which indicates a significant increase from 13.76% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.25% in the past 14 days, which was lower than the 60.78% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.3775, while its 200-day Moving Average is $0.3593. Nevertheless, the first resistance level for the watch stands at $0.4403 in the near term. At $0.4481, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.4538. If the price goes on to break the first support level at $0.4268, it is likely to go to the next support level at $0.4211. Assuming the price breaks the second support level, the third support level stands at $0.4133.
Sio Gene Therapies Inc. (NASDAQ: SIOX) Key Stats
There are currently 72,942K shares outstanding in the company with a market cap of 31.88 million. Presently, the company’s annual sales total 0 K according to its annual income of -71,890 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -3,080 K.